Who makes AD-101 45mg?

AD-101 45mg is developed by Addpharma Inc..

Last reviewed 2026-04-20 · How we verify

AD-101 45mg

Addpharma Inc. · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	AD-101 45mg
Also known as	AD-101
Sponsor	Addpharma Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Evaluating the Pharmacokinetic Characteristics of AD-101 in Healthy Volunteers (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

AD-101 45mg CI brief — competitive landscape report
AD-101 45mg updates RSS · CI watch RSS
Addpharma Inc. portfolio CI